about
The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assaysRationale for short course primaquine in Africa to interrupt malaria transmissionPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateModelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensitySubmicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western KenyaReducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesThe potential contribution of mass treatment to the control of Plasmodium falciparum malariaMosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTargeting asymptomatic malaria infections: active surveillance in control and eliminationThe Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled TrialSerological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial GuineaThe dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in TanzaniaMicro-epidemiological structuring of Plasmodium falciparum parasite populations in regions with varying transmission intensities in AfricaPregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?Quantifying travel behavior for infectious disease research: a comparison of data from surveys and mobile phonesImpact of metric and sample size on determining malaria hotspot boundariesLow density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern TanzaniaRapid assessment of malaria transmission using age-specific sero-conversion rates.Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission.PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation.Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsA barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains.Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.Validation of three geolocation strategies for health-facility attendees for research and public health surveillance in a rural setting in western KenyaSingle dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.Hitting hotspots: spatial targeting of malaria for control and eliminationEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationModeling the cost effectiveness of malaria control interventions in the highlands of western KenyaIgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso.Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.High levels of asymptomatic and subpatent Plasmodium falciparum parasite carriage at health facilities in an area of heterogeneous malaria transmission intensity in the Kenyan highlands.Human immune responses that reduce the transmission of Plasmodium falciparum in African populations.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change.Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria.Continuing intense malaria transmission in northern Uganda.
P50
Q26315349-EF79EC2B-DC4E-452F-BF7E-F1BF4EFF05EFQ27006552-3F512AB2-DBBB-47F8-9111-635C1D653FE4Q28469316-2070D027-9AA1-4289-B260-9E8992D77F15Q28474141-7ACE983D-507B-455B-AF88-D432F4AABA1EQ28474692-7154C08B-9CB1-4541-BC4D-95002613F1F8Q28475084-31968F9A-AF2B-4BDF-A905-00BF1C8ECAA7Q28478260-8654D31F-5013-4BEC-93F1-090786AEF9AEQ28482471-0C341F68-BC61-402F-83F6-F8BB8432321FQ28534608-1777CEFB-15E6-44C9-91AE-34626A9AC5F3Q28551321-7E008D25-7F9A-4819-BFB0-54562109FDF5Q28744515-8E30555E-D9C2-4E92-8DE1-BB156D9316A4Q28744581-33878D4B-AC30-480B-AC1F-58C4B2B6D4DFQ29464553-E28087B7-366A-4E09-B677-1C50E3E96309Q30235017-EBE767DE-D324-4F24-8DBD-AE53E9919669Q30836435-1376437C-EE60-43F1-889B-EAE817B77A1AQ30844998-04CBD1ED-2DC5-423C-A998-D7B8B418B4ECQ33449934-9D8B6826-8667-4010-9FA1-599BF2931ADDQ33475618-A8A2A708-ED69-4828-9877-048D4C449BD3Q33520254-0BDBEF9E-3659-4AAE-BB6E-7B87A91C932FQ33596068-7F49C46E-1F9C-45F8-AEA2-FADD2E3B2416Q33601837-B7959A57-894F-4766-9570-B70560B2E6FFQ33826283-3A00DB2D-0A9A-4A23-9729-A369FA191C01Q33848880-DE7E5E95-7A51-47F8-9C38-2D316F771952Q33898575-99F2A544-00F4-4AE8-9ECA-9C892F49BA73Q33901814-5BAB0A6B-4328-4A9A-A92A-7405E6E117CCQ33915011-E47AEAA4-E38A-4FD4-863A-ADC8C0E2432EQ34038938-3414195D-2575-45FA-BA3F-DB6F69343BBFQ34058341-7BEF6F23-BB26-4894-8188-58F8A92F924AQ34149880-4574152F-4D29-40FF-A5B8-FC54EAE46379Q34177472-2BCE4544-376D-482D-9A1F-496CA9655236Q34301503-49270248-148B-496A-9A1A-F6F92FD8486AQ34328747-80FF9756-57AC-4C55-8CE9-3EAAA53E2CE4Q34488590-99B820CF-5196-4C4A-BC17-79ED0451C983Q34563560-E5F99BE0-A29D-4F45-AECF-43A2F4224428Q34640098-756E979A-71CE-4280-B182-84D3DD9A05A2Q34641186-F4152BA9-0568-409E-8A77-56492420F3E9Q34677891-D30E9DC5-EC39-49AE-8214-EE7DD64A35BEQ34832467-0B5125E8-BB6D-411B-9831-D47F87AE7C00Q34873304-B1E1541D-4104-4570-9120-4389915D6742Q34875874-7C4D3FDF-3319-4D4E-8B91-94914E58689D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Teun Bousema
@ast
Teun Bousema
@en
Teun Bousema
@es
Teun Bousema
@nl
Teun Bousema
@sl
type
label
Teun Bousema
@ast
Teun Bousema
@en
Teun Bousema
@es
Teun Bousema
@nl
Teun Bousema
@sl
prefLabel
Teun Bousema
@ast
Teun Bousema
@en
Teun Bousema
@es
Teun Bousema
@nl
Teun Bousema
@sl
P1053
N-3574-2014
P106
P21
P213
0000 0001 4003 2494
P31
P3829
P496
0000-0003-2666-094X
P569
2000-01-01T00:00:00Z